Ovitrelle® 250 MCG PRE-FIL (CHORIOGONADOTROPIN ALFA 250 MCG / 0.5 ML)

Ovitrelle is indicated For women undergoing superovulation prior to assisted reproductive techniques such as in vitro fertilization (IVF) : Ovitrelle is administered to trigger final follicular maturation AND luteinisation AFTER stimulation of follicular growth. – Anovulatory OR oligo-ovulatory women: Ovitrelle is administered to trigger ovulation AND luteinisation in Anovulatory OR oligo-ovulatory patients AFTER stimulation of follicular growth.